Novo Integrated Sciences, Inc. (NVOS)

Market Cap	14.50M
Revenue (ttm)	13.66M
Net Income (ttm)	-12.08M
Shares Out	19.05M
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	392,515
Open	0.773
Previous Close	0.777
Day's Range	0.732 - 0.787
52-Week Range	0.416 - 5.380
Beta	-0.56
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 15, 2024

About NVOS

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline test...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Sep 22, 2017
• Employees: 127
• Stock Exchange: NASDAQ
• Ticker Symbol: NVOS

Financial Performance

In 2023, NVOS's revenue was $12.57 million, an increase of 7.11% compared to the previous year's $11.74 million. Losses were -$13.21 million, -59.77% less than in 2022.